GREAL

BNP PARIBAS EASY FTSE EPRA Nareit Developed Europe

ETF Euronext / Paris – Stock Market Prices, News & Analysis

Cet ETF suit l'indice FTSE EPRA/NAREIT Developed Europe, concentré sur les FPI et les sociétés immobilières cotées en Europe développée.

immobilier

€ 6.79

0.24 %

Real Estate Real Estate News Europe

BNP PARIBAS EASY FTSE EPRA Nareit Developed Europe

€ 6.79

0.24 %

GREAL

Cet ETF suit l'indice FTSE EPRA/NAREIT Developed Europe, concentré sur les FPI et les sociétés immobilières cotées en Europe développée.

immobilier

Real Estate Real Estate News Europe

Price history of BNP PARIBAS EASY FTSE EPRA Nareit Developed Europe

Performance & Momentum

6 Months 2.95 %

1 Year 1.11 %

3 Years 12.90 %

5 Years 30.55 %

Momentum

Unlock this indicator

Strategic Analysis

BNP PARIBAS EASY FTSE EPRA Nareit Developed Europe • 2026

BNP Paribas Easy FTSE EPRA Nareit Developed Europe is an ETF that replicates the FTSE EPRA/NAREIT Developed Europe index, focusing on real estate investment trusts (REITs) and publicly traded real estate companies in developed European markets. This provides investors with diversified exposure to European real estate markets.

Strengths

Diversified exposure to stable and developed European real estate markets.
Investment in REITs and real estate companies, sectors generally known for stable returns through rents and regular distributions.
Managed by BNP Paribas, a financial institution recognized for its asset management.

Weaknesses

Negative performance in recent months and years, reflecting ongoing challenges in the European real estate sector.
Relatively weak momentum, indicating a current unfavorable trend.

Momentum

The ETF has recorded moderate momentum but is currently declining due to recent underperformance in the real estate sector. This may suggest that investing in this fund is more suitable for those seeking a patient approach or looking at a long-term recovery perspective.

Ask our AI about BNP PARIBAS EASY FTSE EPRA Nareit Developed Europe

Analysis performed 1 month ago